CRESCENT CAPITAL BDC INC CCAP 深 滬
已收盤 08-15 16:00:00 美东时间
15.13
-0.110
-0.72%
華盛通- 最 高15.275
- 今 開15.24
- 成交量 17.62万股
- 最 低 15.0027
- 昨 收 15.24
- 總市值 5.61亿
- 52周最高 19.25
- 市盈率 靜 7.61
- 換手率 0.48%
- 52周最低 13.07
- 委 比 -66.52%
- 總股本 3706.15万
- 歷史最高 19.25
- 量 比 1.04
- 振 幅 1.79%
- 歷史最低 -3.70
- 每 手 1
- 風險率 1.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Crescent Capital BDC NII of $0.46
Crescent Capital BDC press release (NASDAQ:CCAP): Q2 net investment income per share of $0.46. Total investment income of $42.99M. More on Crescent Capital BDC Crescent Capital BDC: Unfairly Discounte...
08-14 04:24
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Crescent Capital BDC Q2 2025 Earnings Preview
Crescent Capital BDC (NASDAQ:CCAP) is scheduled to announce Q2 earnings results on Wednesday, August 13th, after market close. The consensus EPS Estimate is $0.47 and the consensus Revenue Estimate is...
08-13 05:35
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Second Quarter Ended June 30, 2025 Financial Results
Crescent BDC (NASDAQ: CCAP) announced it will release its second quarter 2025 financial results on August 13, 2025 after market close. A webcast/conference call to discuss the results is scheduled for August 14, 2025 at 12:00 p.m. ET, accessible via its website or by dialing (800) 715-9871 with conference ID 1217499. A replay will be available on its site. The company provides capital solutions to middle market firms and is externally managed by ...
07-29 20:05
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
Crescent Capital BDC Navigates Earnings Amid Challenges
Crescent Capital Bdc, Inc. (($CCAP)) has held its Q1 earnings call. Read on for...
05-16 08:25
Crescent Capital BDC Q1 Net investment income per share $0.45 Misses $0.52 Estimate, Total investment income $42.13M Miss $45.08M Estimate
Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.45 per share which missed the analyst consensus estimate of $0.52 by 13.46 percent. This is a 28.57 percent decrease over earnings of $0.63 per share
05-15 04:12
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
Crescent Capital BDC declares $0.42 quarterly dividend
Crescent Capital BDC (NASDAQ:CCAP) declares $0.42/share quarterly dividend. Payable June 13; for shareholders of record May 30; ex-div May 30. The company decide special cash dividends related to undi...
05-13 23:34
Commscope targets $1-1.05B adjusted EBITDA in 2025 amid strong segment growth
Earnings Call Insights: CommScope (COMM) Q1 2025 Management View CEO Charles Treadway reported core net sales of $1.112 billion for Q1 2025, marking a 23% year-over-year increase, with core adjusted E...
05-02 02:39
